ConductScience.org, home

Disease · MONDO_0002508

gingivitis

6 sourcesdiseases-2026-09-18-0.1.0

Download JSON
Cite this record

ConductScience Library. gingivitis. Diseases, record MONDO_0002508. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/MONDO_0002508

On this page

Disease

Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.

Name
gingivitis
Open Targets
Open Targets ID
MONDO_0002508
Open Targets
Other names
Gingival inflammation, Inflamed gums, Red and swollen gums, gingiva inflammation, inflammation of gingiva
Open Targets
Disease Ontology
DOID:3087
Disease Ontology
MeSH
D005891
MeSH
NCI Thesaurus
C34636
NCI Thesaurus
Highest stage of its drugs
Approval, for 5 of its 40 drugs, from DailyMed
Open Targets

Drugs40

The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

DrugChEMBL IDTypeOpen Targets' stageStage reported byReportsOf them trialsTrials shown hereSource
STANNOUS FLUORIDECHEMBL1909079Small moleculeApprovalDailyMed402928Drugs and targets
CHLORHEXIDINE GLUCONATECHEMBL4297088Small moleculeApprovalDailyMed371111Drugs and targets
SODIUM FLUORIDECHEMBL1528Small moleculeApprovalDailyMed1198Drugs and targets
SODIUM MONOFLUOROPHOSPHATECHEMBL1908359Small moleculeApprovalDailyMed1188Drugs and targets
HYDROGEN PEROXIDECHEMBL71595Small moleculeApprovalDailyMed866Drugs and targets
CHLORHEXIDINECHEMBL790Small moleculePhase 3ClinicalTrials.gov323232Drugs and targets
CETYLPYRIDINIUM CHLORIDECHEMBL2003538Small moleculePhase 3ClinicalTrials.gov141414Drugs and targets
FLUORIDECHEMBL1232767Small moleculePhase 3ClinicalTrials.gov141414Drugs and targets
TRICLOSANCHEMBL849Small moleculePhase 3ClinicalTrials.gov887Drugs and targets
THYMOLCHEMBL29411Small moleculePhase 3ClinicalTrials.gov661Drugs and targets

1 to 10 of 40

See all 40 drugs

Targets6

The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.

TargetProteinIts drugs that act on itMechanismsHighest stage of those drugsGene in GenesSource
ARAndrogen receptor1Androgen Receptor antagonistUnknownhttps://conductscience.org/library/genes/367Drugs and targets
C3Complement C31Complement C3 inhibitorPhase 2https://conductscience.org/library/genes/718Drugs and targets
ESR1Estrogen receptor1Estrogen receptor alpha agonistUnknownhttps://conductscience.org/library/genes/2099Drugs and targets
NR3C1Glucocorticoid receptor1Glucocorticoid receptor antagonistUnknownhttps://conductscience.org/library/genes/2908Drugs and targets
PGRProgesterone receptor1Progesterone receptor agonistUnknownhttps://conductscience.org/library/genes/5241Drugs and targets
VDRVitamin D3 receptor1Vitamin D receptor agonistPhase 1https://conductscience.org/library/genes/7421Drugs and targets

Trials111

Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 3 more are not shown, since the checks do not confirm them.

TrialTitlePhaseParticipantsResults first postedConditionsDrugsLinked bySource
NCT03988374Clinical Efficacy Evaluation of Three DentifricesPhase 23192021-08-23Gingival Inflammation and Bleeding, Dental PlaqueSODIUM BICARBONATEIts record names the diseaseClinicalTrials.gov
NCT02750943Potential of Stannous Fluoride Toothpaste to Reduce Gum DiseaseNot applicable2532016-11-11GingivitisSTANNOUS FLUORIDEIts record names the diseaseClinicalTrials.gov
NCT02207907To Evaluate the Efficacy and Tolerability of Sodium Bicarbonate ToothpastePhase 22472017-02-17Oral HygieneSODIUM BICARBONATE, SODIUM FLUORIDEIts record names the diseaseClinicalTrials.gov
NCT02207400To Evaluate Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant OrganismsPhase 22462016-07-26Oral HygieneSODIUM BICARBONATE, SODIUM FLUORIDEIts record names the diseaseClinicalTrials.gov
NCT06660069A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque AccumulationNot applicable1992026-03-18Dental Plaque, GingivitisCETYLPYRIDINIUM CHLORIDE, STANNOUS FLUORIDEIts record names the diseaseClinicalTrials.gov
NCT05654662A Clinical Study Investigating the Effects of a Dentifrice Containing 67% Sodium Bicarbonate When Used Twice Daily for 12 Weeks on Gingivitis Treatment and Plaque RemovalNot applicable1972025-01-13Gingivitis, Dental PlaqueSODIUM BICARBONATEIts record names the diseaseClinicalTrials.gov
NCT06602466A Clinical Study Investigating the Effect of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival HealthNot applicable1752026-01-22Dental Plaque, GingivitisSTANNOUS FLUORIDEIts record names the diseaseClinicalTrials.gov
NCT02243046The Clinical Investigation of a Zinc Based Toothpaste in Reducing Plaque and GingivitisPhase 21622016-05-04Dental Plaque and GingivitisTRICLOSANIts record names the diseaseClinicalTrials.gov
NCT06143670A Clinical Study Investigating the Effects of a Dentifrice Containing 0.454% Stannous Fluoride on Gingivitis Treatment and Plaque Reduction When Used Twice Daily for 12 WeeksNot applicable1592025-03-21GingivitisSODIUM FLUORIDE, STANNOUS FLUORIDEIts record names the diseaseClinicalTrials.gov
NCT04050722A Clinical Study Investigating the Efficacy of a Stannous Fluoride Dentifrice in Improving Gingival Health After Twice Daily Use for 3 WeeksPhase 41302020-11-19GingivitisSODIUM FLUORIDE, STANNOUS FLUORIDEIts record names the diseaseClinicalTrials.gov

1 to 10 of 111

See all 111 trials

Comparisons in its trials18

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

ComparisonGroup 1, with the outcomeGroup 2, with the outcomeParticipantsTrialSource
Stannous Fluoride vs Sodium Monofluorophosphate: serious adverse events0 of 1250 of 128253NCT02750943Trial comparisons
Sodium Bicarbonate Dentrifice vs 0% Sodium Bicarbonate Dentrifice: serious adverse events0 of 1240 of 123247NCT02207907Trial comparisons
Sodium Bicarbonate and Sodium Fluoride Dentifrice vs Sodium Fluoride Dentifrice: serious adverse events0 of 1230 of 123246NCT02207400Trial comparisons
Test Product (Corsodyl Original Toothpaste) vs Reference Product (Colgate Cavity Protection Toothpaste): deaths from any cause0 of 940 of 96190NCT05654662Trial comparisons
Test Product (Corsodyl Original Toothpaste) vs Reference Product (Colgate Cavity Protection Toothpaste): serious adverse events0 of 940 of 96190NCT05654662Trial comparisons
Test Toothpaste vs Reference Toothpaste (Negative Control): deaths from any cause0 of 780 of 83161NCT06602466Trial comparisons
Test Toothpaste vs Reference Toothpaste (Negative Control): serious adverse events0 of 780 of 83161NCT06602466Trial comparisons
Test Product vs Reference Product (Negative Control): deaths from any cause0 of 760 of 76152NCT06143670Trial comparisons
Test Product vs Reference Product (Negative Control): serious adverse events0 of 760 of 76152NCT06143670Trial comparisons
Sensodyne Repair and Protect (Test Dentifrice) vs Colgate Cavity Protection (Negative Control Dentifrice): deaths from any cause0 of 650 of 65130NCT04050722Trial comparisons

Papers from its trials33

The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

PMIDListed asTrials listing itSource
41328922RESULT1PubMed
39275820RESULT1PubMed
39251207RESULT1PubMed
38594113RESULT1PubMed
35968157RESULT1PubMed
35287956RESULT1PubMed
34134691RESULT1PubMed
26427569RESULT1PubMed
25624634RESULT1PubMed
25478471RESULT1PubMed

Data dates

The date of each source this release read.

Open Targets
2026-09-18
Open Targets
Drug links and their checks, from Drugs and targets
2026-09-18
Drugs and targets
ClinicalTrials.gov, from Trials
2026-11-12
Trials
Comparisons, from Trial comparisons
2026-03-23
Trial comparisons
PubMed, for the checks
2026-11-06
PubMed
MeSH, for the checks
2026-11-10
MeSH

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this disease from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0002508

GET https://conductscience.org/api/diseases/v1/MONDO_0002508/drugs?page=2